After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, EXEL falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Exelixis Inc is $9.47B. A total of 2.42 million shares were traded on the day, compared to an average of 2.33M shares.
In the most recent transaction, Hessekiel Jeffrey sold 60,000 shares of EXEL for 36.67 per share on Nov 29 ’24. After the transaction, the EVP & General Counsel now owns 486,059 company shares. In a previous transaction on Nov 29 ’24, JEFFREY HESSEKIEL bought 60,000 shares at 36.67 per share.
Among the insiders who sold shares, Haley Patrick J. disposed of 10,000 shares on Nov 22 ’24 at a per-share price of $35.27. This resulted in the EVP, Commercial holding 278,665 shares of EXEL after the transaction. In another insider transaction, PATRICK JOSEPH HALEY bought 10,000 shares at $35.27 per share on Nov 22 ’24.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, EXEL has a high of $37.59 and a low of $20.01.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. EXEL’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $51.27M in debt and $337.59M in liabilities at the time. Its Book Value Per Share was $7.96, while its Total Shareholder’s Equity was $2.21B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EXEL is Buy with a score of 4.05.
